JAM2
From Wikipedia, the free encyclopedia
|
Junctional adhesion molecule 2
|
|||||||||||
| Identifiers | |||||||||||
| Symbol(s) | JAM2; C21orf43; CD322; JAM-B; JAMB; PRO245; VE-JAM; VEJAM | ||||||||||
| External IDs | OMIM: 606870 MGI: 1933820 HomoloGene: 10929 | ||||||||||
|
|||||||||||
| RNA expression pattern | |||||||||||
|
|
|||||||||||
| Orthologs | |||||||||||
| Human | Mouse | ||||||||||
| Entrez | 58494 | 67374 | |||||||||
| Ensembl | ENSG00000154721 | ENSMUSG00000053062 | |||||||||
| Uniprot | P57087 | Q9JI59 | |||||||||
| Refseq | NM_021219 (mRNA) NP_067042 (protein) |
NM_023844 (mRNA) NP_076333 (protein) |
|||||||||
| Location | Chr 21: 25.93 - 26.01 Mb | Chr 16: 84.66 - 84.71 Mb | |||||||||
| Pubmed search | [1] | [2] | |||||||||
Junctional adhesion molecule 2, also known as JAM2, is a human gene.[1] JAM2 has also been designated as CD322 (cluster of differentiation 322).
Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and water from passing freely through the paracellular space. The protein encoded by this immunoglobulin superfamily gene member is localized in the tight junctions between high endothelial cells. It acts as an adhesive ligand for interacting with a variety of immune cell types and may play a role in lymphocyte homing to secondary lymphoid organs.[1]
[edit] References
[edit] Further reading
- Muller WA (2003). "Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response.". Trends Immunol. 24 (6): 327–34. PMID 12810109.
- Bazzoni G (2004). "The JAM family of junctional adhesion molecules.". Curr. Opin. Cell Biol. 15 (5): 525–30. PMID 14519386.
- Palmeri D, van Zante A, Huang CC, et al. (2000). "Vascular endothelial junction-associated molecule, a novel member of the immunoglobulin superfamily, is localized to intercellular boundaries of endothelial cells.". J. Biol. Chem. 275 (25): 19139–45. doi:. PMID 10779521.
- Hattori M, Fujiyama A, Taylor TD, et al. (2000). "The DNA sequence of human chromosome 21.". Nature 405 (6784): 311–9. doi:. PMID 10830953.
- Cunningham SA, Arrate MP, Rodriguez JM, et al. (2000). "A novel protein with homology to the junctional adhesion molecule. Characterization of leukocyte interactions.". J. Biol. Chem. 275 (44): 34750–6. doi:. PMID 10945976.
- Hartley JL, Temple GF, Brasch MA (2001). "DNA cloning using in vitro site-specific recombination.". Genome Res. 10 (11): 1788–95. PMID 11076863.
- Arrate MP, Rodriguez JM, Tran TM, et al. (2002). "Cloning of human junctional adhesion molecule 3 (JAM3) and its identification as the JAM2 counter-receptor.". J. Biol. Chem. 276 (49): 45826–32. doi:. PMID 11590146.
- Liang TW, Chiu HH, Gurney A, et al. (2002). "Vascular endothelial-junctional adhesion molecule (VE-JAM)/JAM 2 interacts with T, NK, and dendritic cells through JAM 3.". J. Immunol. 168 (4): 1618–26. PMID 11823489.
- Gardiner K, Slavov D, Bechtel L, Davisson M (2002). "Annotation of human chromosome 21 for relevance to Down syndrome: gene structure and expression analysis.". Genomics 79 (6): 833–43. doi:. PMID 12036298.
- Cunningham SA, Rodriguez JM, Arrate MP, et al. (2002). "JAM2 interacts with alpha4beta1. Facilitation by JAM3.". J. Biol. Chem. 277 (31): 27589–92. doi:. PMID 12070135.
- Aurrand-Lions M, Johnson-Leger C, Lamagna C, et al. (2004). "Junctional adhesion molecules and interendothelial junctions.". Cells Tissues Organs (Print) 172 (3): 152–60. PMID 12476045.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:. PMID 12477932.
- Ebnet K, Aurrand-Lions M, Kuhn A, et al. (2004). "The junctional adhesion molecule (JAM) family members JAM-2 and JAM-3 associate with the cell polarity protein PAR-3: a possible role for JAMs in endothelial cell polarity.". J. Cell. Sci. 116 (Pt 19): 3879–91. doi:. PMID 12953056.
- Clark HF, Gurney AL, Abaya E, et al. (2003). "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.". Genome Res. 13 (10): 2265–70. doi:. PMID 12975309.
- Zhang Z, Henzel WJ (2005). "Signal peptide prediction based on analysis of experimentally verified cleavage sites.". Protein Sci. 13 (10): 2819–24. doi:. PMID 15340161.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:. PMID 15489334.
- Wiemann S, Arlt D, Huber W, et al. (2004). "From ORFeome to biology: a functional genomics pipeline.". Genome Res. 14 (10B): 2136–44. doi:. PMID 15489336.
- Liu T, Qian WJ, Gritsenko MA, et al. (2006). "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.". J. Proteome Res. 4 (6): 2070–80. doi:. PMID 16335952.
[edit] External links
 |
This membrane protein-related article is a stub. You can help Wikipedia by expanding it. |
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
